Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)

CAPS Rating: 2 out of 5

A development stage pharmaceutical company that seeks to acquire and develop innovative products for the treatment of a variety of human diseases.

Recs

1
Player Avatar TMFBiologyFool (96.58) Submitted: 2/13/2012 6:00:09 PM : Outperform Start Price: $3.26 CHTP Score: +17.42

Hard to know for sure, but gut says investors are overreacting to the company's characterization of the ad com docs.

Featured Broker Partners


Advertisement